|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
EBSCO_ocn839675796 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr ||||||||||| |
| 008 |
120712s2013 nyua ob 001 0 eng |
| 010 |
|
|
|a 2019725063
|
| 040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d YDXCP
|d EBLCP
|d AGLDB
|d OCLCF
|d VTS
|d AU@
|d STF
|d M8D
|d K6U
|d N$T
|d OCLCO
|d E7B
|d CNSPO
|d YDX
|d OCLCQ
|d SNK
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 841170396
|a 964616134
|a 965127551
|
| 020 |
|
|
|a 9781622574513
|q (eBook)
|
| 020 |
|
|
|a 1622574516
|
| 020 |
|
|
|z 9781622576364
|q (hbk.)
|
| 020 |
|
|
|z 1622576365
|q (hbk.)
|
| 029 |
1 |
|
|a DEBBG
|b BV043775963
|
| 029 |
1 |
|
|a DEBSZ
|b 450736210
|
| 029 |
1 |
|
|a GBVCP
|b 804565902
|
| 035 |
|
|
|a (OCoLC)839675796
|z (OCoLC)841170396
|z (OCoLC)964616134
|z (OCoLC)965127551
|
| 050 |
0 |
0 |
|a QD399
|
| 072 |
|
7 |
|a SCI
|x 013040
|2 bisacsh
|
| 082 |
0 |
4 |
|a 547.590459
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Bioactive heterocycles :
|b synthesis and biological evaluation /
|c K.L. Ameta, R.P. Pawar and A.J. Domb, editors.
|
| 264 |
|
1 |
|a New York :
|b Nova Biomedical,
|c [2013]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Biochemistry research trends
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a BIOACTIVE HETEROCYCLES: SYNTHESIS AND BIOLOGICAL EVALUATION; BIOACTIVE HETEROCYCLES: SYNTHESIS AND BIOLOGICAL EVALUATION; Library of Congress Cataloging-in-Publication Data; Contents; Preface; About the Editors; Contributors; Chapter 1: Multipotent 1,8-Naphthyridines, as New Tacrine Analogues, for the Treatment of Alzheimer's Disease; Abstract; 1. Introduction; 2. 4H-Pyrano [2,3-b]Pyridines (Pyranotacrines); 2.1. Synthesis; 2.2. Pharmacology; 3. Furo and Thieno[2,3-b]pyridines (Furo and Thienotacrines); 3.1. Synthesis; 4. 4-Aryl-1,8-naphthyrydines (Pyridotacrines); 4.1. Synthesis.
|
| 505 |
8 |
|
|a 4.2. PharmacologyConclusion; References; Chapter 2: Pyrrolo [1,2-a] Quinolines: Synthesis and Biological Activity; Abstract; 1. Introduction; 2. Synthetic Routes to Pyrrolo[1,2-a]Quinolines; 2.1. Synthesis Starting from Quinoline and Its Derivatives; 2.2. Synthesis Starting from Pyrroles; 2.3. Other Methods for Obtaining Pyrrolo[1,2-a]Quinolines; 2.4. Bioactive Compounds Based on Pyrrolo[1,2-a]Quinolines; Conclusion; Acknowledgments; References; Chapter 3: Aziridines: Synthesis and Bioactivity; Abstract; 1. Introduction; 2. Overview and General Features; 3. Synthesis of Aziridines.
|
| 505 |
8 |
|
|a 3.1. From Addition to Alkenes3.2. From Ü, Ý-Unsaturated Carbonyl Compounds; 3.3. From Imines; 3.4. From Ring Closure of Haloamines and Amino Alcohols; 3.5. By Ring Transformation of Epoxides; 3.6. Miscellaneous Synthesis; 4. Biological Activity of Aziridines; 4.1. Cytotoxic and Anticancer Activities; 4.2. Antimicrobial Activities; 4.3. Protein Inhibitor Aziridines; 4.4. Antibiotic and Miscellaneous Activities of Aziridines; Conclusion; References; Chapter 4: Bioactivity and Synthesis of Substituted Imidazole Motifs; Abstract; 1. Introduction.
|
| 505 |
8 |
|
|a 2. Biological Importance of Substituted Imidazole Derivatives2.1. Cyclooxygenase-2 (COX-2) Inhibitors Activity of imidazoles; 2.2. Inhibitors of p38 MAP Kinase Activity of imidazoles; 2.3. Combretastatin A-4 (CA-4) Analogues with Antitumor Activity; 2.4. Modulators of P-glycoprotein (P-gp)-mediatedMultidrug Resistance (MDR); 2.5. GSK3 Inhibitors Activities for Substituted imidazoles; 2.6. Anti-inflammatory Activity for Substituted imidazole Derivatives; 2.7. Antimicrobial Activity of Substituted imidazoles i.e. Antibacterial & Antifungal Activity.
|
| 505 |
8 |
|
|a 2.8. Other Biological Activity of Substituted imidazoles3. Methods of Synthesisfor Substituted Imidazoles; Conclusion; References; Chapter 5: Synthesis and Biological Activity of Five-, Six- and Seven-membered S, N-Containing Saturated Heterocycles; Abstract; 1. Introduction; 2. Discussion; 2.1. One-pot Cyclothiomethylation Reaction; 2.2. Biological Activity; Conclusion; References; Chapter 6: Synthesis and Bioactivity of Dihydropyrimidines; Abstract; 1. Introduction; 2. Biological Activities of DHPMs; 2.1. Antifungal Activity; 2.2. Antibacterial Activity; 2.3. Anti-inflammatory Activity.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Heterocyclic compounds
|x Synthesis.
|
| 650 |
|
0 |
|a Bioactive compounds
|x Synthesis.
|
| 650 |
|
6 |
|a Composés hétérocycliques
|x Synthèse.
|
| 650 |
|
6 |
|a Composés bioactifs
|x Synthèse.
|
| 650 |
|
7 |
|a SCIENCE
|x Chemistry
|x Organic.
|2 bisacsh
|
| 650 |
|
7 |
|a Heterocyclic compounds
|x Synthesis
|2 fast
|
| 700 |
1 |
|
|a Ameta, K. L.,
|e editor.
|
| 700 |
1 |
|
|a Pawar, R. P.,
|e editor.
|
| 700 |
1 |
|
|a Domb, A. J.
|q (Abraham J.),
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Bioactive heterocycles.
|d New York : Nova Biomedical, [2013]
|z 9781622576364
|w (DLC) 2012944244
|
| 830 |
|
0 |
|a Biochemistry research trends series.
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=548909
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3020535
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10677640
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 548909
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 9459720
|
| 994 |
|
|
|a 92
|b IZTAP
|
